Page last updated: 2024-08-23

phosphotyrosine and Polycystic Kidney, Autosomal Dominant

phosphotyrosine has been researched along with Polycystic Kidney, Autosomal Dominant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frank, DA; Haque, N; Humphreys, BD; Nelson, EA; Takakura, A; Zandi-Nejad, K; Zhou, J	1

Other Studies

1 other study(ies) available for phosphotyrosine and Polycystic Kidney, Autosomal Dominant

Article	Year
Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Human molecular genetics, 2011, Nov-01, Volume: 20, Issue:21 Topics: Adult; Aminosalicylic Acids; Animals; Animals, Newborn; Benzenesulfonates; Cell Line; Cysts; Disease Models, Animal; Gene Expression; Genes, Reporter; Humans; Kidney; Mice; Mice, Knockout; Phosphorylation; Phosphotyrosine; Polycystic Kidney, Autosomal Dominant; Pyrimethamine; Signal Transduction; STAT3 Transcription Factor	2011

Article

Year

Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways.

Human molecular genetics, 2011, Nov-01, Volume: 20, Issue:21

Topics: Adult; Aminosalicylic Acids; Animals; Animals, Newborn; Benzenesulfonates; Cell Line; Cysts; Disease Models, Animal; Gene Expression; Genes, Reporter; Humans; Kidney; Mice; Mice, Knockout; Phosphorylation; Phosphotyrosine; Polycystic Kidney, Autosomal Dominant; Pyrimethamine; Signal Transduction; STAT3 Transcription Factor

2011